UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden

Annals of oncology, 2020-12, Vol.31 (12), p.1746-1754

2020

Volltextzugriff (PDF)

Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience

Annals of oncology, 2012-01, Vol.23 (1), p.193-200

2012

Volltextzugriff (PDF)

Dielectric characterization of Plasmodium falciparum -infected red blood cells using microfluidic impedance cytometry

Journal of the Royal Society interface, 2018-10, Vol.15 (147), p.20180416

2018

Volltextzugriff (PDF)

The mTOR pathway: a new target in cancer therapy

Current cancer drug targets, 2010-08, Vol.10 (5), p.484-495

2010

Volltextzugriff (PDF)

Three Proposals to Optimise the Eastern Cooperative Oncology Group and Karnofsky Scales in the Molecular and COVID-19 Era

Clinical oncology (Royal College of Radiologists (Great Britain)), 2021-03, Vol.33 (3), p.e192-e192

2021

Volltextzugriff (PDF)

Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells

British journal of cancer, 2012-05, Vol.106 (10), p.1648-1659

2012

Volltextzugriff (PDF)

Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma

Annals of oncology, 2023-03, Vol.34 (3), p.275-288

2023

Volltextzugriff (PDF)

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial

Annals of oncology, 2021-01, Vol.32 (1), p.66-76

2021

Volltextzugriff (PDF)

Lack of growth inhibitory synergism with combined MAPK/PI3K inhibition in preclinical models of pancreatic cancer

Annals of oncology, 2017-11, Vol.28 (11), p.2896-2898

2017

Volltextzugriff (PDF)

AN INFORMATIVE CONTENT 3D MODEL FOR THE HALL HOLDING THE RESURRECTION OF CHRIST BY PIERO DELLA FRANCESCA MURAL PAINTING AT SANSEPOLCRO, ITALY

International archives of the photogrammetry, remote sensing and spatial information sciences., 2019, Vol.XLII-2/W11, p.435-442

2019

Volltextzugriff (PDF)

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

Annals of oncology, 2016-11, Vol.27 (11), p.2074-2081

2016

Volltextzugriff (PDF)

Very elderly patients and lung cancer in a tertiary care center: a real life experience

Annals of oncology, 2017-10, Vol.28, p.vi64-vi64

2017

Volltextzugriff (PDF)

Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study

Annals of oncology, 2015-06, Vol.26 (6), p.1248-1253

2015

Volltextzugriff (PDF)

Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model

Journal of oral pathology & medicine, 2012-11, Vol.41 (10), p.788-792

2012

Volltextzugriff (PDF)

Randomised phase II trial of oral vinorelbine (OV) and cisplatin (P) followed by maintenance with OV versus gemcitabine (GEM) and P followed by maintenance with GEM as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC) patients (pts) with squamous (sq) histological type

Annals of oncology, 2018-10, Vol.29, p.viii520-viii521

2018

Volltextzugriff (PDF)

Pancreatic cancer: sharing a nutrition education project with the patients and their care givers

Annals of oncology, 2017-10, Vol.28, p.vi51-vi52

2017

Volltextzugriff (PDF)

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

Annals of oncology, 2017-12, Vol.28 (12), p.3110-3110

2017

Volltextzugriff (PDF)

Safety of nintedanib plus docetaxel in advanced non-squamous NSCLC (nsNSCLC) patients: The preliminary results of the SENECA (second-line nintedanib in non-small cell lung cancer) trial

Annals of oncology, 2018-10, Vol.29, p.viii506-viii507

2018

Volltextzugriff (PDF)

FOLFOX4/XELOX in stage II–III colon cancer: early survival data of the Italian Three Or Six Colon Adjuvant (TOSCA) trial

Annals of oncology, 2017-10, Vol.28, p.vi1-vi1

2017

Volltextzugriff (PDF)

527 Our Experience on Conservative Mastectomies – Focus on Nipple Areola Complex Sparing Mastectomy (NACSM) and Skin Reducing Mastectomy (SRM)

European journal of cancer (1990), 2012-03, Vol.48, p.S200-S200

2012

Volltextzugriff (PDF)

PO-293 Tumour/stroma interactions in colorectal cancer (CRC) models: role of the tumour suppressor PTEN

ESMO open, 2018-07, Vol.3 (Suppl 2), p.A342-A343

2018

Volltextzugriff (PDF)

Baldness and testicular cancer: the EPSAM case–control study

Andrology (Oxford), 2016-03, Vol.4 (2), p.251-256

2016

Volltextzugriff (PDF)

1155 POSTER Synergistic Interaction Between MEK and MTor Inhibitors in Cancer Cells With PTEN Loss

European journal of cancer (1990), 2011, Vol.47, p.S140-S140

2011

Volltextzugriff (PDF)

1156 POSTER Synergistic Activity of ‘Vertical’ Combinations of Agents Targeting the RAF/MEK/ERK Cascade as a Therapeutic Strategy in Human Tumours

European journal of cancer (1990), 2011, Vol.47, p.S140-S140

2011

Volltextzugriff (PDF)

PO-502 A potential role for hsp90 in her2-driven breast cancer (bc)

ESMO open, 2018-06, Vol.3 (Suppl 2), p.A426-A427

2018

Volltextzugriff (PDF)

1 – 25 von 293

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(250)
Mit Volltextzugriff
(248)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(152)
Humans
(133)
Life Sciences & Biomedicine
(130)
Adult
(65)
Female
(63)
Biological And Medical Sciences
(62)
Male
(61)
Middle Aged
(54)
Medical Sciences
(48)
Aged
(40)
Ophthalmology
(40)
Oncology
(35)
Eye Movements
(31)
Adolescent
(23)
Fundamental And Applied Biological Sciences. Psychology
(17)
Saccades
(15)
Technology
(15)
Accommodation, Ocular
(14)
Time Factors
(13)
Amblyopia - Physiopathology
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden

Impact of dental care in the prevention of bisphosphonate-associated osteonecrosis of the jaw: a single-center clinical experience

Dielectric characterization of Plasmodium falciparum -infected red blood cells using microfluidic impedance cytometry

The mTOR pathway: a new target in cancer therapy

Three Proposals to Optimise the Eastern Cooperative Oncology Group and Karnofsky Scales in the Molecular and COVID-19 Era

Intrinsic resistance to selumetinib, a selective inhibitor of MEK1/2, by cAMP-dependent protein kinase A activation in human lung and colorectal cancer cells

Clonal KEAP1 mutations with loss of heterozygosity share reduced immunotherapy efficacy and low immune cell infiltration in lung adenocarcinoma

Overall survival with 3 or 6 months of adjuvant chemotherapy in Italian TOSCA phase 3 randomised trial

Lack of growth inhibitory synergism with combined MAPK/PI3K inhibition in preclinical models of pancreatic cancer

AN INFORMATIVE CONTENT 3D MODEL FOR THE HALL HOLDING THE RESURRECTION OF CHRIST BY PIERO DELLA FRANCESCA MURAL PAINTING AT SANSEPOLCRO, ITALY

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

Very elderly patients and lung cancer in a tertiary care center: a real life experience

Aprepitant versus metoclopramide, both combined with dexamethasone, for the prevention of cisplatin-induced delayed emesis: a randomized, double-blind study

Exposing human epithelial cells to zoledronic acid can mediate osteonecrosis of jaw: an in vitro model

Randomised phase II trial of oral vinorelbine (OV) and cisplatin (P) followed by maintenance with OV versus gemcitabine (GEM) and P followed by maintenance with GEM as first-line chemotherapy in advanced non-small cell lung cancer (NSCLC) patients (pts) with squamous (sq) histological type

Pancreatic cancer: sharing a nutrition education project with the patients and their care givers

Phase III trial comparing 3-6 months of adjuvant FOLFOX4/XELOX in stage II-III colon cancer: safety and compliance in the TOSCA trial

Safety of nintedanib plus docetaxel in advanced non-squamous NSCLC (nsNSCLC) patients: The preliminary results of the SENECA (second-line nintedanib in non-small cell lung cancer) trial

FOLFOX4/XELOX in stage II–III colon cancer: early survival data of the Italian Three Or Six Colon Adjuvant (TOSCA) trial

527 Our Experience on Conservative Mastectomies – Focus on Nipple Areola Complex Sparing Mastectomy (NACSM) and Skin Reducing Mastectomy (SRM)

PO-293 Tumour/stroma interactions in colorectal cancer (CRC) models: role of the tumour suppressor PTEN

Baldness and testicular cancer: the EPSAM case–control study

1155 POSTER Synergistic Interaction Between MEK and MTor Inhibitors in Cancer Cells With PTEN Loss

1156 POSTER Synergistic Activity of ‘Vertical’ Combinations of Agents Targeting the RAF/MEK/ERK Cascade as a Therapeutic Strategy in Human Tumours

PO-502 A potential role for hsp90 in her2-driven breast cancer (bc)

Suchergebnisse filtern